| Jim G Melton, DO | |
|
3200 Quail Springs Pkwy, Ste 200, Oklahoma City, OK 73134-2612 | |
| (405) 701-9880 | |
| (405) 701-9881 |
| Full Name | Jim G Melton |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 36 Years |
| Location | 3200 Quail Springs Pkwy, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093702011 | NPI | - | NPPES |
| 770001792 | Other | OK | RAILROAD MEDICARE |
| 100130690A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 3168 (Oklahoma) | Secondary |
| 2086S0129X | Surgery - Vascular Surgery | 3168 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oklahoma Heart Hospital South, Llc | Oklahoma city, OK | Hospital |
| Grady Memorial Hospital | Chickasha, OK | Hospital |
| Oklahoma Heart Hospital, Llc | Oklahoma city, OK | Hospital |
| Alliancehealth Woodward | Woodward, OK | Hospital |
| Alliancehealth Midwest | Midwest city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiovascular Health Clinic Pllc | 5597070326 | 19 |
| Advanced Cardiovascular Solutions, Llc | 9335454420 | 7 |
News Archive
Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, are powerfully prognostic, a team of researchers from the Massachusetts General Hospital (MGH) Heart Center has found.
› Verified 8 days ago
| Entity Name | Advanced Cardiovascular Solutions, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053791731 PECOS PAC ID: 9335454420 Enrollment ID: O20150819006760 |
News Archive
Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, are powerfully prognostic, a team of researchers from the Massachusetts General Hospital (MGH) Heart Center has found.
› Verified 8 days ago
| Entity Name | Cardiovascular Health Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215324553 PECOS PAC ID: 5597070326 Enrollment ID: O20150821014510 |
News Archive
Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, are powerfully prognostic, a team of researchers from the Massachusetts General Hospital (MGH) Heart Center has found.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jim G Melton, DO 3200 Quail Springs Pkwy, Ste 200, Oklahoma City, OK 73134-2612 Ph: (405) 701-9880 | Jim G Melton, DO 3200 Quail Springs Pkwy, Ste 200, Oklahoma City, OK 73134-2612 Ph: (405) 701-9880 |
News Archive
Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.
Researchers at The Pennsylvania State University College of Medicine, led by Dr. Ian S. Zagon, have discovered that a novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation. According to BreastCancer.org 1 in 8 women in the U.S. will develop invasive breast cancer and more than 39,000 deaths occur annually.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today that Stephane Boissel, CEO, TxCell and other senior management will either attend, present to, and meet investors at a number of leading forthcoming investor conferences.
Levels of a biomarker used in the diagnosis of heart attacks are almost universally elevated in patients who have undergone coronary-artery bypass grafting (CABG) and, when markedly elevated, are powerfully prognostic, a team of researchers from the Massachusetts General Hospital (MGH) Heart Center has found.
› Verified 8 days ago
Dr. Beverly Jean Talbert, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 825 Ne 10th St, Oupb5350, Oklahoma City, OK 73104 Phone: 405-271-4864 Fax: 405-271-1643 | |
Michael Taylor Heath, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6308 | |
Dr. Teresa Marie Shavney, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Nw Expressway, Suite 420, Oklahoma City, OK 73112 Phone: 405-713-9935 Fax: 405-713-9936 | |
Dr. Mary Kathleen Lindemuth, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 10900 Hefner Pointe Dr, Oklahoma City, OK 73120 Phone: 405-552-0400 Fax: 405-752-4251 | |
John Stephen Chaffin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 760, Oklahoma City, OK 73112 Phone: 405-951-4345 Fax: 405-951-4392 | |
Juan Claros-sorto, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6308 | |
Ananth Srinivasan, MBBS Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Nw Expressway, Oklahoma City, OK 73112 Phone: 405-949-3349 Fax: 405-945-5467 |